The Value of Cytokeratin 5/6, p63 and Thyroid Transcription Factor-1 in Adenocarcinoma, Squamous Cell Carcinoma and Non-Small-Cell Lung Cancer of the Lung

被引:16
|
作者
Argon, Asuman [1 ]
Nart, Deniz [2 ]
Veral, Ali [2 ]
机构
[1] Izmir Bozyaka Educ & Res Hosp, Dept Med Pathol, Izmir, Turkey
[2] Ege Univ, Fac Med, Dept Pathol, Izmir, Turkey
关键词
Adenocarcinoma; Squamous cell carcinoma; Immunohistochemistry; Lung cancer;
D O I
10.5146/tjpath.2015.01302
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Objective: It is now important to distinguish between adenocarcinoma and squamous cell carcinoma of the lung because of target-specific treatments. Our study aimed to study the efficiency of Thyroid Transcription Factor-1 (TTF-1), cytokeratin 5/6 (CK5/6) and p63 in distinguishing between adenocarcinoma and squamous cell carcinoma and to study the contribution of these markers to the diagnosis in non-small cell lung cancer. Material and Method: Immunohistochemically, TTF-1, CK 5/6 and p63 were used in 72 cases of squamous cell carcinoma, 19 cases of adenocarcinoma, and 29 cases of non-small cell lung cancer whose final diagnosis was decided with the subsequent resection material. The specificity, sensitivity, and positive and negative predictive value were calculated for each marker. Results: TTF-1 positivity was seen in none of the 72 squamous cell carcinomas but in all of 19 adenocarcinoma cases. CK5/6 negativity was seen in all cases of adenocarcinoma and in two cases of squamous cell carcinoma. p63 was positive in all squamous cell carcinomas and in 4 adenocarcinomas. Cytokeratin 5/6, p63 positivity and TTF-1 negativity were observed in 17 non-small cell lung cancers whose final diagnosis was squamous cell carcinoma. None of the 12 non-small cell lung cancers whose final diagnosis was adenocarcinoma exhibited positive staining for CK5/6. However, p63 staining was not seen in the biopsy but was focal in the surgical specimen in one case. All the 12 non-small cell lung cancers whose certain diagnosis was adenocarcinoma were positive for TTF-1. TTF-1, CK 5/6 and p63 seem to be useful for differentiating adenocarcinoma from squamous cell carcinoma with 100% specificity, 100% sensitivity and 100% specificity, 97% sensitivity and 87% specificity, and 100% sensitivity, respectively. Conclusion: We concluded that TTF-1 is a reliable marker for subtyping lung cancer. Different staining patterns can be seen with CK5/6 and p63; however, if they are used together with TTF-1 and interpreted correctly, they can be of help for the final diagnosis even in cases in which the morphology is unclear.
引用
收藏
页码:81 / 88
页数:8
相关论文
共 50 条
  • [1] Evaluation of Napsin A, Cytokeratin 5/6, p63, and Thyroid Transcription Factor 1 in Adenocarcinoma Versus Squamous Cell Carcinoma of the Lung
    Whithaus, Kenneth
    Fukuoka, Junya
    Prihoda, Thomas J.
    Jagirdar, Jaishree
    [J]. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2012, 136 (02) : 155 - 162
  • [2] Value of P63 in distinguishing squamous cell carcinoma from adenocarcinoma of the lung
    Conde, Esther
    Angulo, Barbara
    Redondo, Pilar
    Garcia-Garcia, Elena
    Suarez-Gauthier, Ana
    Garcia Lujan, Ricardo
    Lopez-Encuentra, Angel
    Paz-Ares, Luis
    Lopez-Rios, Fernando
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S878 - S878
  • [3] Role of thyroid transcription factor-1 and P63 immunocytochemistry in cytologic typing of non-small cell lung carcinomas
    Abu Sinna, Eman
    Ezzat, Noha
    Sherif, Ghada M.
    [J]. JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2013, 25 (04) : 209 - 218
  • [4] ROLE OF P40 (ΔNP63), P63, THYROID TRANSCRITPION FACTOR-1 AND NAPSIN A IN DIFFERENTIAL DIAGNOSIS BETWEEN LUNG SQUAMOUS CELL CARCINOMA AND LUNG ADENOCARCINOMA
    Sun, Tingyi
    Xie, Hongjian
    Kong, Lingfei
    [J]. ACTA MEDICA MEDITERRANEA, 2014, 30 (04): : 923 - 927
  • [5] Various Antibody Clones of Napsin A, Thyroid Transcription Factor 1, and p40 and Comparisons With Cytokeratin 5 and p63 in Histopathologic Diagnostics of Non-Small Cell Lung Carcinoma
    Tran, Lena
    Mattsson, Johanna S. M.
    Nodin, Bjorn
    Jonsson, Per
    Planck, Maria
    Jirstrom, Karin
    Botling, Johan
    Micke, Patrick
    Brunnstrom, Hans
    [J]. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2016, 24 (09) : 648 - 659
  • [6] Expression of p63 as predictive and prognostic factor in advanced non-small-cell lung cancer
    Cvetkovic, Gordana
    Plavec, Goran
    Tatomirovic, Zeljka
    Jovic, Milena
    Loncarevic, Olivera
    Trifunovic, Zoran
    Vukovic, Jelena
    Stojsavljevic, Marko
    Milic, Gordana
    [J]. VOJNOSANITETSKI PREGLED, 2018, 75 (04) : 366 - 373
  • [7] Analysis of thyroid transcription factor-1 and cytokeratin 20 separates merkel cell carcinoma from small cell carcinoma of lung
    Hanly, AJ
    Elgart, GW
    Jorda, M
    Smith, J
    Nadji, M
    [J]. JOURNAL OF CUTANEOUS PATHOLOGY, 2000, 27 (03) : 118 - 120
  • [8] Prognostic value of thyroid transcription factor-1 in primary, resected, non-small cell lung carcinoma
    Puglisi, F
    Barbone, F
    Damante, G
    Bruckbauer, M
    Di Lauro, V
    Beltrami, CA
    Di Loreto, C
    [J]. MODERN PATHOLOGY, 1999, 12 (03) : 318 - 324
  • [9] Non-small cell lung carcinoma with diffuse coexpression of thyroid transcription factor-1 and ΔNp63/p40
    Hayashi, Takuo
    Takamochi, Kazuya
    Yanai, Yuka
    Mitani, Keiko
    Tomita, Hisashi
    Mogushi, Kaoru
    Suehara, Yoshiyuki
    Takahashi, Fumiyuki
    Suzuki, Kenji
    Saito, Tsuyoshi
    Yao, Takashi
    [J]. HUMAN PATHOLOGY, 2018, 78 : 177 - 181
  • [10] Relationship of thyroid transcription factor 1 to EGFR status in non-small-cell lung cancer
    Sheffield, B. S.
    Bosdet, I. E.
    Ali, R. H.
    Young, S. S.
    McNeil, B. K.
    Wong, C.
    Dastur, K.
    Karsan, A.
    Ionescu, D. N.
    [J]. CURRENT ONCOLOGY, 2014, 21 (06) : 305 - 308